Xiamen comaka Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Xiamen comaka Technology Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include UNIFINE and PARAS KORS. The owner is based in Fujian Province.
302J, No. 16, Wanghai Road
Software Park Phase II,Xiamen
Fujian Province 361000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiamen comaka Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Precious metals and their alloys; jewellery, precious stones; horological instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Xiamen comaka Technology Co., Ltd. have?
Xiamen comaka Technology Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Xiamen comaka Technology Co., Ltd. file in?
Xiamen comaka Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 18 (Leather Goods). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.
What are Xiamen comaka Technology Co., Ltd.'s most well-known trademarks?
Xiamen comaka Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as UNIFINE and PARAS KORS. These are among 3 currently registered trademarks in the portfolio.
What is Xiamen comaka Technology Co., Ltd.'s trademark registration success rate?
Xiamen comaka Technology Co., Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.